SEARCH

SEARCH BY CITATION

Appendix S1. Results for the secondary analysis population.

Table S1. (corresponds to main Table 2) Demographics and patient characteristics (N = 94).

Table S2. (corresponds to main Table 3) Drug use and days of treatment on non-biologic therapies 12 months before and 12 months after biologic therapy initiation (N = 94).

Table S3. (corresponds to main Table 4) Number of patients and days of treatment on biologic therapies 12 months after initiation (N = 94).

Table S4. (corresponds to main Table 5) Cost of drugs 12 months before and 12 months after biologic therapy initiation (N = 94).

Table S5. Hospital resource use 12 months before and 12 months after biologic therapy initiation (N = 94).

Table S6. (corresponds to main Table 6) Cost of inpatient and outpatient admissions 12 months before and 12 months after biologic therapy initiation (N = 94).

Please note: Wiley-Blackwell are not responsible for the content or functionality of any supporting materials supplied by the authors. Any queries (other than missing material) should be directed to the corresponding author for the article.

FilenameFormatSizeDescription
BJD_9944_sm_tables.doc138KSupporting info item

Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.